GRM3 and depressive symptom measurement: ACPD-induced LTD is also a balanced outcome; in that case between two competing plasticity processes, activation of group I mGluRs leads to increased PKA and results in depression, while activation of the group II receptor mGluR3 yields potentiation through inhibition of PKA [15].